You can access the original SEC filing by clicking here.
Ownership Summary Table
Name | Sole Voting Power | Shared Voting Power | Sole Dispositive Power | Shared Dispositive Power | Aggregate Amount Owned Power | Percent of Class |
---|---|---|---|---|---|---|
OrbiMed Advisors | 0 | 3,298,516 | 0 | 3,298,516 | 3,298,516 | 23.76% |
OrbiMed Capital GP VI | 0 | 3,298,516 | 0 | 3,298,516 | 3,298,516 | 23.76% |
Samuel D. Isaly | 0 | 3,298,516 | 0 | 3,298,516 | 3,298,516 | 23.76% |
Follow Sam Isaly's OrbiMed Advisors
Page 1 of 10 – SEC Filing
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Under the Securities Exchange Act of 1934
Common Stock, par value $0.001 per share
OrbiMed Capital GP VI LLC
Samuel D. Isaly
New York, NY 10022
Telephone: (212) 739‑6400
Authorized to Receive Notices and Communications)
July 24, 2017
Follow Alpine Immune Sciences Inc. (NASDAQ:ALPN)
Follow Alpine Immune Sciences Inc. (NASDAQ:ALPN)
Page 2 of 10 – SEC Filing
CUSIP No. 02083G100 | Page 2 of 11 Pages | ||||
1 | NAME OF REPORTING PERSONS OrbiMed Advisors LLC | ||||
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions) (a) ☐ (b) ☐ | ||||
3 | SEC USE ONLY | ||||
4 | SOURCE OF FUNDS (See Instructions) AF | ||||
5 | CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) | ☐ | |||
6 | CITIZENSHIP OR PLACE OF ORGANIZATION Delaware | ||||
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | 7 | SOLE VOTING POWER 0 | |||
8 | SHARED VOTING POWER 3,298,516 | ||||
9 | SOLE DISPOSITIVE POWER 0 | ||||
10 | SHARED DISPOSITIVE POWER 3,298,516 | ||||
11 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 3,298,516 | ||||
12 | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions) | ☐ | |||
13 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 23.76% * | ||||
14 | TYPE OF REPORTING PERSON (See Instructions) IA |
Follow Alpine Immune Sciences Inc. (NASDAQ:ALPN)
Follow Alpine Immune Sciences Inc. (NASDAQ:ALPN)
Page 3 of 10 – SEC Filing
CUSIP No. 02083G100 | Page 3 of 11 Pages | ||||
1 | NAME OF REPORTING PERSONS OrbiMed Capital GP VI LLC | ||||
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions) (a) ☐ (b) ☐ | ||||
3 | SEC USE ONLY | ||||
4 | SOURCE OF FUNDS (See Instructions) AF | ||||
5 | CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) | ☐ | |||
6 | CITIZENSHIP OR PLACE OF ORGANIZATION Delaware | ||||
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | 7 | SOLE VOTING POWER 0 | |||
8 | SHARED VOTING POWER 3,298,516 | ||||
9 | SOLE DISPOSITIVE POWER 0 | ||||
10 | SHARED DISPOSITIVE POWER 3,298,516 | ||||
11 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 3,298,516 | ||||
12 | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions) | ☐ | |||
13 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 23.76%* | ||||
14 | TYPE OF REPORTING PERSON (See Instructions) OO |
Follow Alpine Immune Sciences Inc. (NASDAQ:ALPN)
Follow Alpine Immune Sciences Inc. (NASDAQ:ALPN)
Page 4 of 10 – SEC Filing
CUSIP No. 02083G100 | Page 4 of 11 Pages | ||||
1 | NAME OF REPORTING PERSONS Samuel D. Isaly | ||||
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions) (a) ☐ (b) ☐ | ||||
3 | SEC USE ONLY | ||||
4 | SOURCE OF FUNDS (See Instructions) AF | ||||
5 | CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) | ☐ | |||
6 | CITIZENSHIP OR PLACE OF ORGANIZATION United States | ||||
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | 7 | SOLE VOTING POWER 0 | |||
8 | SHARED VOTING POWER 3,298,516 | ||||
9 | SOLE DISPOSITIVE POWER 0 | ||||
10 | SHARED DISPOSITIVE POWER 3,298,516 | ||||
11 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 3,298,516 | ||||
12 | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions) | ☐ | |||
13 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 23.76%* | ||||
14 | TYPE OF REPORTING PERSON (See Instructions) IN |
Follow Alpine Immune Sciences Inc. (NASDAQ:ALPN)
Follow Alpine Immune Sciences Inc. (NASDAQ:ALPN)
Page 5 of 10 – SEC Filing
Item 1. | Security and Issuer |
Item 2. | Identity and Background |
Item 3. | Source and Amount of Funds or Other Consideration |
Follow Alpine Immune Sciences Inc. (NASDAQ:ALPN)
Follow Alpine Immune Sciences Inc. (NASDAQ:ALPN)
Page 6 of 10 – SEC Filing
Item 4. | Purpose of Transaction |
Item 5. | Interest in Securities of the Issuer |
Follow Alpine Immune Sciences Inc. (NASDAQ:ALPN)
Follow Alpine Immune Sciences Inc. (NASDAQ:ALPN)
Page 7 of 10 – SEC Filing
Item 6. | Contracts, Arrangements, Understandings or Relationship with Respect to Securities of the Issuer |
Item 7. | Materials to Be Filed as Exhibits |
Exhibit | Description |
1. | Joint Filing Agreement among OrbiMed Advisors LLC, OrbiMed Capital GP VI LLC and Samuel D. Isaly. |
2. | Form of Lock-Up Agreement. |
Follow Alpine Immune Sciences Inc. (NASDAQ:ALPN)
Follow Alpine Immune Sciences Inc. (NASDAQ:ALPN)
Page 8 of 10 – SEC Filing
OrbiMed Advisors LLC | ||||
By: | /s/ Samuel D. Isaly | |||
Name: | Samuel D. Isaly | |||
Title: | Managing Member |
OrbiMed Capital GP VI LLC | ||||
By: | OrbiMed Advisors LLC its Managing Member | |||
By: | /s/ Samuel D. Isaly | |||
Name: | Samuel D. Isaly | |||
Title: | Managing Member | |||
Samuel D. Isaly | ||||
By: | /s/ Samuel D. Isaly | |||
Name: | Samuel D. Isaly |
Follow Alpine Immune Sciences Inc. (NASDAQ:ALPN)
Follow Alpine Immune Sciences Inc. (NASDAQ:ALPN)
Page 9 of 10 – SEC Filing
Name | Position with Reporting Person | Principal Occupation |
Samuel D. Isaly | Managing Member | Managing Member OrbiMed Advisors LLC |
Carl L. Gordon | Member | Member OrbiMed Advisors LLC |
Sven H. Borho German and Swedish Citizen | Member | Member OrbiMed Advisors LLC |
Jonathan T. Silverstein | Member | Member OrbiMed Advisors LLC |
W. Carter Neild | Member | Member OrbiMed Advisors LLC |
Geoffrey C. Hsu | Member | Member OrbiMed Advisors LLC |
Evan D. Sotiriou | Chief Financial Officer | Chief Financial Officer OrbiMed Advisors LLC |
Follow Alpine Immune Sciences Inc. (NASDAQ:ALPN)
Follow Alpine Immune Sciences Inc. (NASDAQ:ALPN)
Page 10 of 10 – SEC Filing
Exhibit | Description |
1. | Joint Filing Agreement among OrbiMed Advisors LLC, OrbiMed Capital GP VI LLC and Samuel D. Isaly. |
2. | Form of Lock-Up Agreement. |
11